Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Chinese PLA General Hospital
Welcome,
Profile
Billing
Logout
10 Products
9 Diseases
10 Products
18 Trials
51 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
C-CAR011
/ AbelZeta Pharma
CART-138
/ Chinese PLA General Hospital
CART-33
/ Chinese PLA General Hospital
GC008t
/ AstraZeneca
BCMA-PD1-CART Cells
/ Chinese PLA General Hospital
Beianting
(bevacizumab biosimilar) / Betta Pharma, Chinese PLA General Hospital, Beijing Mabworks Biotech
CART-30
/ AbelZeta Pharma
CART-EGFR
/ AbelZeta Pharma
CART-HER-2
/ AbelZeta Pharma, Chinese PLA General Hospital
CAS001
/ Chinese PLA General Hospital
CD19-PD1-CART cell
/ Chinese PLA General Hospital
HypoSti.CAR-HER2 T
/ Chinese PLA General Hospital
KRAS-EphA-2-CAR-DC
/ Chinese PLA General Hospital
MPTK-CAR-T cells
/ Chinese PLA General Hospital, AstraZeneca
MSC-IFNα
/ Wuxi Sinotide New Drug Discovery Institutes, Chinese PLA General Hospital
TP53-EphA-2-CAR-DC
/ Chinese PLA General Hospital
allogeneic γδ T cell therapy
/ Chinese PLA General Hospital
autologous TRAC locus-inserted CD19-STAR-T
/ Chinese PLA General Hospital
